Login / Signup

Visceral leishmaniasis complicated by hemophagocytic lymphohistiocytosis: A case report from a nonendemic area.

Anwar I JoudehHussein A Elsiddig AwadelkarimMohammadshah Isam GulMahmoud Salm ElayanaDina Sameh SolimanAliaa AmerMusaed Alsamawi
Published in: Clinical case reports (2023)
Visceral leishmaniasis and hemophagocytic lymphohistiocytosis share many clinical features in common and may coexist in the same patient. Visceral leishmaniasis should be promptly ruled out in patients coming from endemic areas before starting immunosuppressive therapy for hemophagocytic lymphohistiocytosis. The mainstay treatment, in this case, is anti-leishmania medications preferably liposomal amphotericin-B.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • case report
  • patient reported outcomes
  • smoking cessation
  • combination therapy